Loading...
Drug Developer Begins Trial of Autism Treatment
Research
Drug Developer Begins Trial of Autism Treatment
2022-02-02 17:29:14
by Alexa Hornbeck

WASHINGTON — Yamo Pharmaceuticals recently enrolled its first patient in a phase 2 clinical trial that may result in medicines able to treat the core behaviors of autism spectrum disorder. “There are 20 million or more people with autism around... Read More

Health
Diagnostic Aid Offers New Approach to Detecting Early Autism
2021-06-11 14:44:21
by Alexa Hornbeck

The FDA has authorized the first aid for diagnosing Autism Spectrum Disorder in children 18 months through 5 years of age called Canvas Dx. It was developed by Cognoa, a behavioral health company.  “Currently, pediatricians refer most children with suspected... Read More

Straight From The Well